Q2 2017 Holdings
Filed 2017-08-14 | 66 holdings | $20.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $7.7M | 275,000 | 36.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $4.9M | 175,000 | 23.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.2M | 196,287 | 19.9% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $3.8M | 675,000 | 18.0% |
| Clovis Oncology Inc(CLVSEUR)Call | COM | 189464100 | $28.2K | 301,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $27.0K | 350,000 | 0.1% |
| Portola Pharmaceuticals IncPut | COM | 737010108 | $22.5K | 400,000 | 0.1% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $16.7K | 300,000 | 0.1% |
| Avexis Inc | COM | 05366U100 | $15.6K | 190,000 | 0.1% |
| Seattle Genetics Inc | COM | 812578102 | $15.5K | 300,000 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $15.2K | 425,000 | 0.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $13.1K | 150,000 | 0.1% |
| Merck & Co Inc(MRK)Call | COM | 58933Y105 | $12.8K | 200,000 | 0.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $12.5K | 125,000 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $12.3K | 165,000 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $12.2K | 100,000 | 0.1% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $11.2K | 200,000 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $10.6K | 1,200,000 | 0.1% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $10.3K | 80,000 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $9.8K | 825,000 | 0.0% |
| Endo Intl PLC | SHS | G30401106 | $8.4K | 750,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $8.2K | 275,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.2K | 475,000 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $7.9K | 400,000 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $7.7K | 100,000 | 0.0% |
| Spectranetics CorpCall | COM | 84760C107 | $7.7K | 200,000 | 0.0% |
| Exelixis Inc(EXEL)Put | COM | 30161Q104 | $7.4K | 300,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $7.2K | 200,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $7.0K | 50,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.9K | 150,000 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $6.5K | 260,000 | 0.0% |
| Currencyshs Brit Pound Ster | BRIT POUND STE | 23129S106 | $6.5K | 50,900 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $6.4K | 150,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR)Call | COM | 46116X101 | $6.2K | 500,000 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $6.2K | 375,000 | 0.0% |
| Novadaq Technologies Inc | COM | 66987G102 | $5.9K | 500,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $5.8K | 350,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $5.5K | 45,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $5.3K | 75,000 | 0.0% |
| Kite Pharma IncCall | COM | 49803L109 | $5.2K | 50,000 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $5.1K | 250,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $4.9K | 350,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $4.9K | 750,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $4.2K | 300,000 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $4.1K | 175,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $4.0K | 550,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.0K | 50,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.7K | 650,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $3.7K | 200,000 | 0.0% |
| K2m Group Hldgs Inc | COM | 48273J107 | $3.7K | 150,000 | 0.0% |